Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+10.34%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$5.32B
AUM Growth
+$623M
(+13%)
Cap. Flow
+$354M
Cap. Flow
% of AUM
6.65%
Top 10 Holdings %
Top 10 Hldgs %
31.02%
Holding
1,573
New
308
Increased
332
Reduced
859
Closed
60
Top Buys
| 1 |
Equinix
EQIX
|
$41.9M |
| 2 |
American Tower
AMT
|
$33.5M |
| 3 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
$28M |
| 4 |
Crown Castle
CCI
|
$20.9M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
$13.7M |
Top Sells
| 1 |
Apple
AAPL
|
$89.3M |
| 2 |
Microsoft
MSFT
|
$66.1M |
| 3 |
Amazon
AMZN
|
$63.1M |
| 4 |
Meta Platforms (Facebook)
META
|
$26.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$25.2M |
Sector Composition
| 1 | Real Estate | 18.33% |
| 2 | Technology | 16.47% |
| 3 | Consumer Discretionary | 8.8% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
1226
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $106K | ﹤0.01% |
4,303
+2,906
| +208% | +$71.6K |
|
1227
Kura Oncology
KURA
$713M
| $104K | ﹤0.01% |
3,176
+1,804
| +131% | +$59.1K |
|
1228
Heron Therapeutics
HRTX
$201M
| $102K | ﹤0.01% |
4,800
+794
| +20% | +$16.9K |
|
1229
Pembina Pipeline
PBA
$22.1B
| $102K | ﹤0.01% |
+4,329
| New | +$102K |
|
|
VXRT
1230
DELISTED
Vaxart
VXRT
| $102K | ﹤0.01% |
+17,786
| New | +$102K |
|
|
KRTX
1231
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $101K | ﹤0.01% |
990
+58
| +6% | +$5.92K |
|
|
BELFB
1232
Bel Fuse Class B
BELFB
$1.82B
| $100K | ﹤0.01% |
6,644
+2,260
| +52% | +$34K |
|
|
VG
1233
DELISTED
Vonage Holdings Corporation
VG
| $99K | ﹤0.01% |
7,654
-1,458
| -16% | -$18.9K |
|
1234
WIX.com
WIX
$8.52B
| $98K | ﹤0.01% |
+394
| New | +$98K |
|
|
NVTA
1235
DELISTED
Invitae Corporation
NVTA
| $97K | ﹤0.01% |
2,330
-4,170
| -64% | -$174K |
|
1236
CommScope
COMM
$3.55B
| $96K | ﹤0.01% |
7,137
-152,673
| -96% | -$2.05M |
|
1237
Cardiff Oncology
CRDF
$144M
| $96K | ﹤0.01% |
+5,362
| New | +$96K |
|
|
SWTX
1238
DELISTED
SpringWorks Therapeutics
SWTX
| $95K | ﹤0.01% |
+1,310
| New | +$95K |
|
1239
Box
BOX
$4.75B
| $93K | ﹤0.01% |
5,125
-244
| -5% | -$4.43K |
|
1240
Replimune Group
REPL
$494M
| $92K | ﹤0.01% |
+2,404
| New | +$92K |
|
1241
Galapagos
GLPG
$2.2B
| $91K | ﹤0.01% |
922
+464
| +101% | +$45.8K |
|
1242
Revolution Medicines
RVMD
$7.57B
| $90K | ﹤0.01% |
+2,272
| New | +$90K |
|
1243
Coca-Cola Europacific Partners
CCEP
$40.4B
| $88K | ﹤0.01% |
+1,761
| New | +$88K |
|
1244
Teva Pharmaceuticals
TEVA
$21.7B
| $87K | ﹤0.01% |
9,031
-2,024
| -18% | -$19.5K |
|
1245
Ryanair
RYAAY
$32.1B
| $86K | ﹤0.01% |
1,963
-385
| -16% | -$16.9K |
|
1246
Dynavax Technologies
DVAX
$1.18B
| $84K | ﹤0.01% |
18,775
+12,306
| +190% | +$55.1K |
|
1247
Vericel Corp
VCEL
$1.72B
| $83K | ﹤0.01% |
2,686
-924
| -26% | -$28.6K |
|
1248
Regenxbio
RGNX
$490M
| $79K | ﹤0.01% |
1,734
-612
| -26% | -$27.9K |
|
|
IGMS
1249
DELISTED
IGM Biosciences
IGMS
| $78K | ﹤0.01% |
884
+529
| +149% | +$46.7K |
|
1250
uniQure
QURE
$985M
| $75K | ﹤0.01% |
+2,072
| New | +$75K |
|